Myeloid acute leukocy

The article was written by PGS. TS.BS Yi Hyeon Gyu – Head of Hematological and Cell Therapy Unit and Dr. Pham Thi Viet Huong – Unit of Hematological and Cell Therapy, Share99 Times City International Health Hub.

<!– –>

Myeloid acute leukocytes (now abbreviated as AML) are a cancer of blood cells and bone marrow. The disease affects a group of white blood cells called bone marrow cells because they are produced in the bone marrow. The concept of "level" means that the disease develops and progresses rapidly, requiring immediate treatment.

1. What is myeloid acute leukocy?

Normally, bone marrow cells and other blood cells are produced in the bone marrow (the software is in the middle of the bone marrow) according to a carefully operated form. In some people with AML, the process is abnormal. There are a large number of abnormal and inage bone marrow cells that are produced, thickening the pulp cavity, and being tossed into the bloodstream. In this inmed adult state, these cells are not able to perform their normal function.

2. Symptoms of myeloid acute leukocy?

The over-growth of these cells leads to an insufficient number of healthy, normal cells, including white blood cells, red blood cells, and tinglets. This can lead to:

  • Leukocytosis (low neutity leukocytosis count) – Neu polycythemias are a type of leukocytosis that helps fight infections. People with leukocytic deficiency are susceptible to infection. Therefore, patients may have common symptoms such as fever, cough, increased sputum secretity.
  • Anemia (low red blood cell population) – Red blood cells that circulating in blood vessels and carrying oxygen to tissues. People who do not have a sufficient number of skin esthenosis can be pale and often tired and have difficulty breathing.
  • Tinglet deficiency (low number of tinglets) – Tinglets are small cells in the blood that help prevent and stop bleeding. People with low number of tinglets may suffer from bleeding and bruising singularly.

AML

Some symptoms of myeloid acute leukocy

3. How can we treat myeloid leukemia?

A lot of chemical drugs are effective against AML. The goal of treatment is to destroy malignant cells without damage to the remaining healing bone marrow cells.

The genetic variations of abnormal bone marrow cells are very variable, which affects how you respond to treatment. Your treatment may have to adjust based on careful analysis of your genetic changes. Generally these genetic changes are not believed to be due to inheritance from the previous life, but rather by accidental development.

The treatment of AML depends on the specific subgroup of the AML. For example, people with a specific AML, also known as "pre-myeloid leukocytes", can be treated with other drugs. The treatment also depends on your age and other accompanying conditions.

Often the treatment of AML is divided into 2 phases: attack creates regression and treatment after regression.

3.1 Attack creates regression in myeloid leukocyst

The first phase in treatment is called attack that creates regression or offensive treatment. Attack treatment (with chemical drugs) is given with the goal of reducing the number of pathology white blood cells to uns detectable levels and thus helping to restore the production of normal blood cells.

Chemotherapy means taking medications to stop or slow down the growth and survival of cancer cells. Chemotherapy is aimed at growing cells, preventing their ability to divide and grow. Since most normal adult cells do not grow actively anymore, they are not as affected by chemotherapy as cancer cells.

However, normal cells in the bone marrow (where blood cells are born), hair cells and the mucosa of the digestive canal are growing cells. The effects of chemotherapy on these cells and other normal tissues cause side effects during treatment, such as hair loss, vomiting, anemia (low red blood cell numbers), an increased risk of infection (low white blood cell population), and bleeding (low number of tinglets).

Chemical treatment is carried out for several days and then leukocyukocyukocyukocyym will persist for about 3 weeks. Often most chemical infusions have to be done while you stay in the hospital because supportive care is required with intravenous antibiotics and often blood transfusions are required.

Complete regression – The first goal of AML treatment is to achieve complete regression. Complete regression means that there are no more malignant white blood cells in the blood or in the bone marrow, the bone marrow is functioning normally, and the normal number of healthy blood cells returns in the circulating blood stream. Bone marrow biopsy and blood tests are required to determine this.

Myeloid acute leukocy

People with leukemia need early treatment

3.2 Post-retracement treatment of AML

Post-retracement treatment is aimed at destroying malignant white blood cells left in the bone marrow or blood without detection at microcepable levels.

There are 2 basic post-regression treatment options:

  • Further chemotherapy treatment, sometimes called post-regressive reinforcement therapy
  • Stem cell transplantation from a healthy giver (hetero-stem cell transplantation)

The "best" post-regression treatment depends on and a lot of factors, including how the patient's AML progresses or is resistant to treatment. Patients with AML may be grouped for risk based on genetic tests of their malignant white blood cells

Stem cell transplantation is not recommended for all AML patients. Serious complications in, even sometimes death, occur quite often after stem cell transplantation than chemotherapy. In a particular group of patients, there are no pronounced benefits of stem cell transplantation compared to chemotherapy. However, stem cell transplantation may be suitable for some people, such as those with very advanced AML, which has relapsed after a period of regression, and those who do not achieve complete regression after initial attack treatment.

3.3 Treatment of AML in older adults

In general, patients over the age of 60 do not respond well to treatment. This involves some of the following factors:

Malignant white blood cells that are difficult to treat (chemical resistant) may be common in older adults. This means that AML in older adults tends to be more resistant to more standard chemical drugs.

In older adults, the presence of other simultaneous diseases such as diabetes, kidney, lung, cardiovascular diseases is an increased risk of complications related to treatment.

  • The best decisions to treat AML for older adults are based on each case. Less strong regimens should be applied. If the potential risks of chemotherapy outn outn out of benefits, then mild care should be recommended. Generally mild care includes blood transfusions if anemia or bleeding and taking antibiotics as needed to treat infections.

AML

AML affects myeloid line cells, says Anthony Baker, CMI, Ohio State University Cancer Center

Share99 International Health Hub is one of the hospitals that not only ensures professional quality with a team of leading doctors, modern technology equipment system but also stands out for comprehensive and professional medical examination, consultation and treatment services; civilized, polite, safe and sterilized medical examination and treatment space.

Customers can directly go to Share99 Health System nationwide for examination or contact the hotline here for assistance.

<!– –>

Article reference source: Uptodate

SEE MORE:

  • The role of bone marrow biopsy
  • In what cases does leukocyukocyukocyity decrease?
  • Bone marrow cell line acute leukocytes (AML): Classification
SEE MORE:

  • Seemingly receiving the death penalty for blood cancer, the patient recovered after just over 1 year of treatment
  • Diagnosis of leukemia (blood cancer)
  • What is leukemia?

About: John Smith

b1ffdb54307529964874ff53a5c5de33?s=90&r=gI am the author of Share99.net. I had been working in Vinmec International General Hospital for over 10 years. I dedicate my passion on every post in this site.

RELATED POSTS:

Leave a Comment

0 SHARES
Share
Tweet
Pin